Pharming (PHAR) Debt Ratio (2019 - 2026)

Pharming's (PHAR) quarterly Debt Ratio came in at 0.2 in Q2 2026, down 3.46% YoY from 0.2 in Q2 2025, and up 3.46% on a QoQ basis from 0.19 in Q1 2026.

Pharming (PHAR) Debt Ratio (2019 - 2026) Analysis & Trends

Pharming (PHAR) has 8 years of Debt Ratio data on file, last reported at 0.2 in Q2 2026.

  • Quarterly Debt Ratio fell 3.46% year-over-year to 0.2 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.2 (down 3.46% YoY) and the FY2025 annual result came in at 0.19, up 154.98% from the prior year.
  • Debt Ratio advanced to 0.2 in Q2 2026, from 0.19 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.35 in Q1 2022 to a low of 0.32 in Q3 2024.
  • A 5-year average of 0.17 and a median of 0.2 in 2025 frame the typical range for Debt Ratio.
  • Annual changes were most pronounced in 2022 — Debt Ratio surged 43996211.97% — and 2024, when it slumped 206.68%.
  • Tracing PHAR's Debt Ratio over 5 years: stood at 0.0 in 2022, then dropped by 5.09% to 0.0 in 2023, then surged by 169.31% to 0.01 in 2024, then soared by 1647.42% to 0.19 in 2025, then grew by 6.47% to 0.2 in 2026.
  • The last three Debt Ratio figures came in at 0.2 (Q2 2026), 0.19 (Q1 2026), and 0.19 (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 0.05
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 0.12
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 0.47
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 0.26
10 Pharming 824.47 Mn 666.19 Mn 141.47 Mn 0.20

Historic Data

Download Data
DateValue
Jun 30, 2026 0.20
Mar 31, 2026 0.19
Dec 31, 2025 0.19
Sep 30, 2025 0.20
Jun 30, 2025 0.20
Mar 31, 2025 0.21
Dec 31, 2024 0.01
Sep 30, 2024 -0.32
Jun 30, 2024 0.21
Mar 31, 2024 0.31
Dec 31, 2023 0.00
Sep 30, 2023 0.30
Jun 30, 2023 0.31
Mar 31, 2023 0.32
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.33
Mar 31, 2022 0.35
Dec 31, 2021 0.76
Sep 30, 2021 0.35